#non-small-cell lung cancer

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

Lung Cancer 101

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

Lung Cancer 101

Tagrisso

Risk-Based Lung Cancer Screening Is More Cost-Effective

Models based on personal risk may be more useful than those based on age and smoking history alone.

Earlier Smoking Cessation May Improve Lung Cancer Survival

Study findings suggest that quitting smoking can have lasting health benefits, even for those who develop lung cancer.

Many Elderly People with Advanced Cancer Receive Aggressive End-of-Life Care

Treatment has shifted to immunotherapy, but survival gains have been small for people over age 75.

Targeted Therapy Allows Certain Lung Cancer Patients to Avoid Whole-Brain Radiation

Targeted therapies can reduce the size and number of brain metastases; patients could then have better-tolerated radiation therapy.

Imfinzi Before and After Surgery Improved Outcomes for Patients With Non-Small-Cell Lung Cancer

People treated with a durvalumab-based regimen before and after surgery had a 32% lower risk of disease recurrence or progression.

MUST read

Teresa (right) and her sister Joyce (left)

When the Caregiver Becomes the Patient: Teresa’s Lung Cancer Story [SPONSORED]

A Better Treatment Approach for “Atypical” Lung Cancers

My Life Stopped the Second I Got This Diagnosis

Lung-Sparing Surgery Is Effective for Some People With Early-Stage Lung Cancer

For some patients, it may be adequate to remove only the section of a lung lobe that contains a tumor.

Now Approved Cancer Drugs — Spring 2023

Newly FDA-approved drugs for ovarian, bladder, liver cancer, and more.

TIGIT Checkpoint Inhibitor Improves Response in People with Lung Cancer

Combination therapy that includes a novel antibody is superior to immunotherapy alone for advanced non-small-cell lung cancer.

People With HIV Can Benefit From Lung Cancer Screening

Screening is recommended for current and former heavy smokers ages 50 to 80, but HIV-positive people may benefit from earlier screening.

FDA Approves Second KRAS Drug for Lung Cancer

Krazati led to tumor shrinkage in 43% of previously treated NSCLC patients with KRAS G12C mutations.

Conquering Fear and Metastatic Lung Cancer

Emotions play a powerful role in living with cancer, a truth AJ Patel learned a decade ago when he was diagnosed with metastatic lung cancer

Lung Cancer Awareness Month

November is Lung Cancer Awareness Month.

Most People Skip Follow-Up Lung Cancer Screening

Although most people screened meet the USPSTF criteria, only one in five returned for a follow-up test a year later.

Libtayo Immunotherapy OK’d for More Lung Cancer Patients

The checkpoint inhibitor is now approved for people with advanced non-small-cell lung cancer regardless of PD-L1 biomarker levels.

People Living With HIV Are at Greater Risk for Lung Cancer

However, lung cancer incidence among HIV-positive people has fallen over the past two decades.

#non-small-cell lung cancer

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

Lung Cancer 101

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

Lung Cancer 101

Tagrisso

Risk-Based Lung Cancer Screening Is More Cost-Effective

Earlier Smoking Cessation May Improve Lung Cancer Survival

Many Elderly People with Advanced Cancer Receive Aggressive End-of-Life Care

Targeted Therapy Allows Certain Lung Cancer Patients to Avoid Whole-Brain Radiation

Imfinzi Before and After Surgery Improved Outcomes for Patients With Non-Small-Cell Lung Cancer

MUST read

When the Caregiver Becomes the Patient: Teresa’s Lung Cancer Story [SPONSORED]

A Better Treatment Approach for “Atypical” Lung Cancers

My Life Stopped the Second I Got This Diagnosis

Lung-Sparing Surgery Is Effective for Some People With Early-Stage Lung Cancer

Now Approved Cancer Drugs — Spring 2023

TIGIT Checkpoint Inhibitor Improves Response in People with Lung Cancer

People With HIV Can Benefit From Lung Cancer Screening

FDA Approves Second KRAS Drug for Lung Cancer

Conquering Fear and Metastatic Lung Cancer

Lung Cancer Awareness Month

Most People Skip Follow-Up Lung Cancer Screening

Libtayo Immunotherapy OK’d for More Lung Cancer Patients

People Living With HIV Are at Greater Risk for Lung Cancer

Science News

Ask Cancer Health